跳至主要内容
临床试验/NCT00727948
NCT00727948已完成早期 1 期

The Impact of the Anti-Platelet Agent Aspirin on Angiogenesis Proteins in Women With Breast Cancer

University of Vermont1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
11
试验地点
1
主要终点
Changes in pro-angiogenic and anti-angiogenic protein levels.

研究概览

简要总结

Changes in major angiogenic proteins have been seen following initiation of tamoxifen and aromatase inhibitor therapy in women with breast cancer. One source of these proteins is the circulating platelet pool. The investigators hypothesize that in addition to their anti-platelet properties, agents such as aspirin can be used as targeted anti-angiogenesis therapy. The investigators will determine the influence of aspirin on the release of angiogenic proteins from platelets in 35 patients with breast cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 95 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Histologically or cytologically proven breast cancer
  • Pre or post-menopausal
  • Completed adjuvant non-hormonal therapy >30 days prior to initiation of study (surgery and/or chemotherapy and/or radiation therapy)
  • Platelet count and hemoglobin within normal ranges for local lab within 30 days of initiation of study therapy
  • Receiving tamoxifen therapy for at least 90 days prior to initiation of study therapy, and is expected to continue that therapy for the duration of the study (75 days)

排除标准

  • Chemotherapy, radiation therapy or surgery within 30 days of study therapy
  • Current use of aspirin, anti-platelet or anti-coagulation agents on a continuous basis
  • Prior history of gastrointestinal or central nervous system bleeding, or documented or self-reported blood in stools or bright red blood per rectum

研究组 & 干预措施

receive aspirin

Experimental

干预措施: Aspirin (Drug)

结局指标

主要结局

Changes in pro-angiogenic and anti-angiogenic protein levels.

时间窗: 75 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chris Holmes

Associate Professor of Medicine

University of Vermont

研究点 (1)

Loading locations...

相似试验